These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prospective, naturalistic study of open-label OROS methylphenidate treatment in Chinese school-aged children with attention-deficit/hyperactivity disorder. Zheng Y, Wang YF, Qin J, Wang LW, Zou LP, Jin XM, Xu T, Wang Y, Qi YL, Gong ME, Yin QY, Mai JN, Jing J, Luo XY, Ma HW, Li HB, Xie L, Li Y, Kuang GF, Yi MJ, Wang F, Zhu XH, Yao YB. Chin Med J (Engl); 2011 Oct; 124(20):3269-74. PubMed ID: 22088519 [Abstract] [Full Text] [Related]
3. Effects of Atomoxetine and Osmotic Release Oral System-Methylphenidate on Executive Functions in Patients with Combined Type Attention-Deficit/Hyperactivity Disorder. Ince Tasdelen B, Karakaya E, Oztop DB. J Child Adolesc Psychopharmacol; 2015 Aug; 25(6):494-500. PubMed ID: 26218871 [Abstract] [Full Text] [Related]
12. Efficacy of Methylphenidate Hydrochloride Extended-Release Capsules (Aptensio XR™) in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Phase III, Randomized, Double-Blind Study. Wigal SB, Nordbrock E, Adjei AL, Childress A, Kupper RJ, Greenhill L. CNS Drugs; 2015 Apr; 29(4):331-40. PubMed ID: 25877989 [Abstract] [Full Text] [Related]
14. The relationship between symptomatic and functional changes of Korean children and adolescents with attention-deficit/hyperactivity disorder treated with osmotic-controlled release oral delivery system-methylphenidate. Kim E, Cheon KA, Joung YS, Kim JY, Song DH. Clin Neuropharmacol; 2015 Apr; 38(1):30-5. PubMed ID: 25580917 [Abstract] [Full Text] [Related]
17. [Switching from a short-acting to a long-acting methylphenidate preparation: a multicentre, open study in children with ADHD]. Heger S, Trott GE, Meusers M, Schulz E, Rothenberger A, Rettig K, Medori R, Schreiner A, Remschmidt H, Vertreter der deutschen C-2000-045-Studiengruppe. Z Kinder Jugendpsychiatr Psychother; 2006 Jul; 34(4):257-65. PubMed ID: 16927568 [Abstract] [Full Text] [Related]
18. Functional improvement and correlations with symptomatic improvement in adults with attention deficit hyperactivity disorder receiving long-acting methylphenidate. Buitelaar JK, Casas M, Philipsen A, Kooij JJ, Ramos-Quiroga JA, Dejonckheere J, van Oene JC, Schäuble B. Psychol Med; 2012 Jan; 42(1):195-204. PubMed ID: 21733214 [Abstract] [Full Text] [Related]
19. Exploring the impact of once-daily OROS® methylphenidate (MPH) on symptoms and quality of life in children and adolescents with ADHD transitioning from immediate-release MPH. Kordon A, Stollhoff K, Niederkirchner K, Mattejat F, Rettig K, Schäuble B. Postgrad Med; 2011 Sep; 123(5):27-38. PubMed ID: 21904084 [Abstract] [Full Text] [Related]